1. Home
  2. HOWL vs ZDGE Comparison

HOWL vs ZDGE Comparison

Compare HOWL & ZDGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • ZDGE
  • Stock Information
  • Founded
  • HOWL 2017
  • ZDGE 2008
  • Country
  • HOWL United States
  • ZDGE United States
  • Employees
  • HOWL N/A
  • ZDGE N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • ZDGE Computer Software: Prepackaged Software
  • Sector
  • HOWL Health Care
  • ZDGE Technology
  • Exchange
  • HOWL Nasdaq
  • ZDGE Nasdaq
  • Market Cap
  • HOWL 37.9M
  • ZDGE 40.3M
  • IPO Year
  • HOWL 2021
  • ZDGE N/A
  • Fundamental
  • Price
  • HOWL $0.87
  • ZDGE $2.37
  • Analyst Decision
  • HOWL Strong Buy
  • ZDGE
  • Analyst Count
  • HOWL 3
  • ZDGE 0
  • Target Price
  • HOWL $9.00
  • ZDGE N/A
  • AVG Volume (30 Days)
  • HOWL 232.7K
  • ZDGE 35.6K
  • Earning Date
  • HOWL 05-08-2025
  • ZDGE 06-09-2025
  • Dividend Yield
  • HOWL N/A
  • ZDGE N/A
  • EPS Growth
  • HOWL N/A
  • ZDGE N/A
  • EPS
  • HOWL N/A
  • ZDGE N/A
  • Revenue
  • HOWL $1,143,000.00
  • ZDGE $29,412,000.00
  • Revenue This Year
  • HOWL N/A
  • ZDGE N/A
  • Revenue Next Year
  • HOWL $733.33
  • ZDGE $1.07
  • P/E Ratio
  • HOWL N/A
  • ZDGE N/A
  • Revenue Growth
  • HOWL N/A
  • ZDGE 4.26
  • 52 Week Low
  • HOWL $0.60
  • ZDGE $1.73
  • 52 Week High
  • HOWL $6.34
  • ZDGE $4.38
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 46.85
  • ZDGE 54.49
  • Support Level
  • HOWL $0.80
  • ZDGE $1.97
  • Resistance Level
  • HOWL $0.97
  • ZDGE $2.65
  • Average True Range (ATR)
  • HOWL 0.07
  • ZDGE 0.20
  • MACD
  • HOWL 0.02
  • ZDGE 0.01
  • Stochastic Oscillator
  • HOWL 41.92
  • ZDGE 58.82

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About ZDGE Zedge Inc. Class B

Zedge Inc provides content distribution platforms. Its content platform enables consumers to personalize their mobile devices with free, high-quality ringtones, wallpapers, home screen app icons, widgets and notification sounds as well as paint, a generative AI wallpaper maker, GuruShots, a skill-based photo challenge game, and Emojipedia. The company also launched a Zedge app. It has two reportable segments, which are the Zedge Marketplace and GuruShots.

Share on Social Networks: